TWIST1 and esophageal squamous cell carcinoma: Mastermind like1 (MAML1) is a key transcription coactivator of this pathway, which could promote the aggressiveness of ESCC through an upregulation of the EMT marker TWIST1 and increase the therapy resistance of ESCC stem cells, respectively [126,127].